Impact of incidental findings on neuroimaging research using functional MR imaging.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 19279275)

Published in AJNR Am J Neuroradiol on March 11, 2009

Authors

S Ulmer, U R Jensen, O Jansen, H M Mehdorn, J Schaub, G Deuschl, H R Siebner

Articles cited by this

Toward a uniform policy for handling incidental findings in neuroimaging research. AJNR Am J Neuroradiol (2008) 1.41

Articles by these authors

30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet (2006) 7.88

Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med (2013) 6.37

CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke (2002) 3.74

A practical guide to diagnostic transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol (2012) 2.60

Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol (2008) 2.53

Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet (1997) 2.40

Decreased corticospinal excitability after subthreshold 1 Hz rTMS over lateral premotor cortex. Neurology (2001) 2.20

A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke (1999) 2.10

Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol (2007) 1.99

Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J Neurol Neurosurg Psychiatry (2001) 1.98

Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. AJNR Am J Neuroradiol (2000) 1.94

Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry (1998) 1.94

Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke (1998) 1.90

Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology (1996) 1.81

Brain tumor imaging in clinical trials. AJNR Am J Neuroradiol (2008) 1.73

Cemento-ossifying fibroma of the petromastoid region: case report and review of the literature. J Laryngol Otol (1997) 1.72

What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry (1998) 1.69

Comparison of CT with diffusion-weighted MRI in patients with hyperacute stroke. Neuroradiology (2001) 1.68

Task-related changes in the effect of magnetic brain stimulation on spinal neurones in man. J Physiol (1993) 1.65

Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours. Stroke (2002) 1.62

Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype. Neurology (2008) 1.60

Age-related decrease in paired-pulse intracortical inhibition in the human primary motor cortex. Neurosci Lett (2001) 1.59

The gait disorder of advanced essential tremor. Brain (2001) 1.57

MR imaging of the optic nerve sheath in patients with craniospinal hypotension. AJNR Am J Neuroradiol (2010) 1.56

Manganese and chronic hepatic encephalopathy. Lancet (1995) 1.47

Abnormal plasticity of sensorimotor circuits extends beyond the affected body part in focal dystonia. J Neurol Neurosurg Psychiatry (2007) 1.47

The effect of subthalamic nucleus stimulation on autogenic inhibition in Parkinson disease. Neurology (2004) 1.45

Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport. Curr Mol Med (2002) 1.45

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease. Eur J Neurol (2006) 1.45

Applications of magnetic cortical stimulation. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl (1999) 1.44

Clinical and radiological evaluation of long-term results of stereotactic proton beam radiosurgery in patients with cerebral arteriovenous malformations. J Neurosurg (1994) 1.43

Persistent hypoglossal artery: MRI, MRA and digital subtraction angiography. Neuroradiology (2001) 1.42

Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des (2007) 1.41

Evidence for distinct cognitive deficits after focal cerebellar lesions. J Neurol Neurosurg Psychiatry (2004) 1.33

Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol (2001) 1.29

Stent-protected angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy: SPACE2 - a three-arm randomised-controlled clinical trial. Int J Stroke (2009) 1.27

Potential of CT angiography in acute ischemic stroke. AJNR Am J Neuroradiol (1997) 1.26

Selective affection of hippocampal CA-1 neurons in patients with transient global amnesia without long-term sequelae. Brain (2006) 1.26

Eye movement abnormalities in essential tremor may indicate cerebellar dysfunction. Brain (2003) 1.26

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24

Hypothalamic deep brain stimulation for cluster headache: experience from a new multicase series. Cephalalgia (2008) 1.24

Focal lesions of human hippocampal CA1 neurons in transient global amnesia impair place memory. Science (2010) 1.23

Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke (2000) 1.23

Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobiol Dis (2003) 1.22

Neuronal activity of the human subthalamic nucleus in the parkinsonian and nonparkinsonian state. J Neurophysiol (2008) 1.20

Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI. Lancet (1999) 1.20

Continuous monitoring of cerebrovascular autoregulation: a validation study. J Neurol Neurosurg Psychiatry (2002) 1.19

Serial analysis of the apparent diffusion coefficient time course in human stroke. Neuroradiology (2002) 1.18

Fanconi-Bickel syndrome--the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Eur J Pediatr (1998) 1.18

High concordance for essential tremor in monozygotic twins of old age. Neurology (2004) 1.18

Determinants of physiologic tremor in a large normal population. Clin Neurophysiol (2000) 1.18

Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Brain (2005) 1.18

Essential tremor and cerebellar dysfunction: abnormal ballistic movements. J Neurol Neurosurg Psychiatry (2002) 1.17

Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts. J Neurol Neurosurg Psychiatry (2003) 1.17

Functional MRI of cortical activations induced by transcranial magnetic stimulation (TMS). Neuroreport (2001) 1.17

Long-latency responses in human thenar muscles mediated by fast conducting muscle and cutaneous afferents. Neurosci Lett (1985) 1.17

Gait analysis during treadmill and overground locomotion in children and adults. Electroencephalogr Clin Neurophysiol (1997) 1.17

Value of coronal reformations in the CT evaluation of acute head trauma. AJNR Am J Neuroradiol (2009) 1.17

Criteria for the diagnosis of essential tremor. Neurology (2000) 1.17

Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma. J Neurooncol (2004) 1.17

Results of magnetic resonance imaging in long-term manganese dioxide-exposed workers. Environ Res (2001) 1.16

Cerebral autoregulation testing after aneurysmal subarachnoid hemorrhage: the phase relationship between arterial blood pressure and cerebral blood flow velocity. Crit Care Med (2001) 1.15

The basal ganglia are hyperactive during the discrimination of tactile stimuli in writer's cramp. Brain (2006) 1.13

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease. Eur J Neurol (2006) 1.13

Malignant peripheral nerve sheath tumours--report of 8 cases and review of the literature. Acta Neurochir (Wien) (2001) 1.13

Gait analysis in idiopathic normal pressure hydrocephalus--which parameters respond to the CSF tap test? Clin Neurophysiol (2000) 1.12

Effector-independent representations of simple and complex imagined finger movements: a combined fMRI and TMS study. Eur J Neurosci (2003) 1.12

Spontaneous intracranial haematomas caused by neoplasms. Acta Neurochir (Wien) (2000) 1.12

Typical features of cerebellar ataxic gait. J Neurol Neurosurg Psychiatry (2002) 1.11

Slow-oscillatory transcranial direct current stimulation can induce bidirectional shifts in motor cortical excitability in awake humans. Neuroscience (2010) 1.10

High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology (2006) 1.10

Animal models of tremor. Mov Disord (1999) 1.08

Event-related desynchronization and movement-related cortical potentials on the ECoG and EEG. Electroencephalogr Clin Neurophysiol (1994) 1.07

Carotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists' collaboration. Stroke (2013) 1.07

Deep brain stimulation in the subthalamic area is more effective than nucleus ventralis intermedius stimulation for bilateral intention tremor. Acta Neurochir (Wien) (2007) 1.06

Brain activity is similar during precision and power gripping with light force: an fMRI study. Neuroimage (2008) 1.06

Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2)(15)O-PET. Brain (1999) 1.06

Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis. Acta Neurol Scand (2012) 1.05

The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05

From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Brain (1999) 1.05

Probable multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry (2004) 1.05

Multiple oscillators are causing parkinsonian and essential tremor. Mov Disord (2000) 1.05

Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration. J Neuroimmunol (2003) 1.04

Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology (2007) 1.04

Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology (2008) 1.03

Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology (1998) 1.03

Longitudinal manganese and copper balances in young infants and preterm infants fed on breast-milk and adapted cow's milk formulas. Br J Nutr (1989) 1.03

In vivo studies of the phenylalanine-4-hydroxylase system in hyperphenylalaninemics and phenylketonurics. Helv Paediatr Acta (1978) 1.02

Excretion of pterins in phenylketonuria and phenylketonuria variants. Helv Paediatr Acta (1980) 1.02

Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-alpha-glucosidase in human fetal and adult tissues and cultured cells. Clin Chim Acta (1985) 1.01